GAAP

Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share

SCHAFFHAUSEN, Switzerland, July 30 /PRNewswire-FirstCall/ -- ($ millions, except per-share amounts) Q3 2009 Q3 2008 % Change ------- ------- -------- Revenue ...

Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook

MORRISTOWN, N.J., July 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and specialty branded pharmaceuticals, today reported net income of $53.0 million, or $0.46 per diluted share. Excluding special items as detailed in the reconciliati...

Medco Delivers Fourth-Quarter GAAP Diluted EPS Growth of 42 Percent; 2008 Full-Year GAAP Diluted EPS Growth of 31 Percent

Record Full-Year 2008 Mail-Order Volume of Nearly 106 Million Prescriptions Strong 2009 EPS Guidance Reaffirmed Fourth-Quarter 2008 Highlights: - GAAP diluted EPS increased 42.1 percent to $0.54 from $0.38 in 2007 - Diluted EPS, excluding $0.05 in amortization of intangible assets fr...

Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63

2009 GAAP Diluted EPS Guidance Reflects Growth of 15 to 21 Percent FRANKLIN LAKES, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Third-Quarter Highlights: -- GAAP diluted EPS increased 48.7 percent to a record $0.58 from $0.39 in third-quarter 2007 -- Diluted EPS, excluding $0.05 in a...

Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance

Second-Quarter Year-Over-Year Highlights: - Record GAAP diluted EPS increased 34.2 percent to $0.51 from $0.38 in second-quarter 2007 - Record diluted EPS increased 30.2 percent to $0.56 from $0.43 in second-quarter 2007, excluding $0.05 in amortizati...

drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007

- Highest Revenues, Gross Margins and Net Income in Company History BELLEVUE, Wash., Feb. 6 /PRNewswire-FirstCall/ -- drugstore.com, inc. (Nasdaq: DSCM ), a leading online provider of health, beauty, vision, and pharmacy products, today announced its financial results for the fourth quarter...

MDS Issues MDS US GAAP Primer

Preparing Investors for MDS' conversion from Canadian to US GAAP Filing TORONTO, Jan. 25 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today issued an MDS US GAAP Primer in anticipation of filing its 20...

Barr Reports Third Quarter 2007 GAAP Earnings of $0.36 Per Share; Adjusted Earnings of $0.75 Per Share

- Strong Generic and Proprietary Revenue Growth - Stable Alliance and Development Revenue - $20 Million Increase in R&D Investment WOODCLIFF LAKE, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) today reported net earning...

MDS Inc. Files Restated 2007 Quarterly Reports Under US GAAP

TORONTO, Feb. 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, has filed restated 2007 quarterly reports under US GAAP, as required by applicable Canadian regulations, after filing its 2007 annual report...

Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance

...e Company's reported results in accordance with US gaap to CNI and adjusted earnings before interest, taxe...ay be required by law. Reconciliations to gaap Net Income CNI To supplement its condense...omputation of CNI. CNI is defined as the Company's gaap net income adjusted for the after-tax effects of t...

GAAP in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...ar Financial Results On a gaap basis, Isis reported a loss from operations of $4....lease refer to the reconciliation of pro forma and gaap measures, which is explained later in this release...overy activities into new therapeutic areas. On a gaap basis, Isis' operating expenses from continuing op...

Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status

...s. We continue to target our AZ-004 NDA submission for the first quarter of 2010." Financial Results - Periods Ended March 31, 2009 and 2008 gaap operating expenses were $16.4 million and $19.2 million in the quarters ended March 31, 2009 and 2008, respectively. In January 2009, the Company ann...

Amicus Therapeutics Announces Second Quarter 2008 Financial Results

...financings in 2008. The differences between U.S. gaap and non U.S. gaap financial results are itemized in Tables 2 and 3, ...d in isolation or as a substitute for reported, or gaap net loss and diluted net loss per common share. ...

Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates

...airs and commercial operations as we prepare for the future commercialization of AZ-004." Financial Results - Periods Ended June 30, 2008 and 2007 gaap operating expenses were $20.5 million and $39.7 million in the quarter and six month period ended June 30, 2008, compared to $14.2 million and $28.0 m...

Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent

...global sales expected to be around $350-400 million, based on current expectation of the competitive environment - Expected to be accretive for Non gaap earnings by the second half of 2010 - Acquisition to bring worldwide rights to FIRAZYR (Icatibant), a peptide based therapeutic for HAE which has ...

Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status

...d $36.5 million in the comparable periods in 2006. gaap operating expenses were $17.4 million in the fourt...pensation expense. The differences in non-GAAP and gaap numbers are reconciled in the tables below (in tho... 2007 2006 gaap net loss $(13,17...

Amicus Therapeutics Announces Second Quarter 2007 Financial Results

...ended June 30, 2006. The differences between U.S. gaap EPS, net loss, research and development and genera... Warrant Stock Compen- gaap as Non-GAAP Liability ... Warrant Stock Deemed Compen- gaap as Non-GAAP Liability Accreti...

GAAP in Biological News

Aware, Inc. Reports Second Quarter 2009 Financial Results

...d in isolation from, and are not a substitute for, gaap measures. A reconciliation of gaap to non-GAAP results has been provided in the attached financial tables. The gaap net loss for the second quarter of 2009 was $1.6 m...

Aware, Inc. Reports First Quarter 2009 Financial Results

...d in isolation from, and are not a substitute for, gaap measures. A reconciliation of gaap to non-GAAP results has been provided in the attached financial tables. The gaap net loss for the first quarter of 2009 was $2.1 mi...

Aware, Inc. Reports First Quarter 2009 Financial Results

...d in isolation from, and are not a substitute for, gaap measures. A reconciliation of gaap to non-GAAP results has been provided in the attached financial tables. The gaap net loss for the first quarter of 2009 was $2.1 mi...

Aware, Inc. Reports Fourth Quarter and 2008 Financial Results

...d in isolation from, and are not a substitute for, gaap measures. A reconciliation of gaap to non-GAAP results has been provided in the attached financial tables. gaap net income for the fourth quarter of 2008 was $5.0...

Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008

...rporate networks and resources. gaap to Non gaap Reconciliation The following charges for the...ourth quarter and full year of 2008, reconcile the gaap and non-GAAP earnings per share: ...

Synaptics Reports Record Results for First Quarter of Fiscal 2009

...st quarter ended September 30, 2008. The Company's gaap results reflect the expensing of non-cash share-ba...ement of the Company's financial performance under gaap and should not be considered as an alternative to gaap net income. The Company presents net income exclud...

BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008

...d, "These financial results are a milestone event for the company. Indeed, within our emerging industry, few of our peers can match our achievement of gaap profitability. Our results reflect the efficacy of our strategy, the superiority of our technology, the rising market interest in biometrics and mobil...

BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008

...d, "These financial results are a milestone event for the company. Indeed, within our emerging industry, few of our peers can match our achievement of gaap profitability. Our results reflect the efficacy of our strategy, the superiority of our technology, the rising market interest in biometrics and mobil...

Digimarc Board Approves $310 Million All-Cash Offer from L-1 Identity Solutions for Digimarc's ID Systems Business

...and making acquisitions. Unlevered free cash flow is not necessarily comparable to similar measures used by other entities and is not a substitute for gaap measures of liquidity such as cash flows from operating activities. Forward Looking Statements This press release contains forward-looking stateme...

Aware, Inc. Reports Fourth Quarter and 2007 Financial Results

...d in isolation from, and are not a substitute for, gaap measures. A reconciliation of gaap to non-GAAP results has been provided in the attached financial tables. gaap net income for the fourth quarter of 2007 was $0.2...

GAAP in Biological Technology

Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010

First-Quarter 2009 Highlights: - GAAP diluted EPS increased 16.0 percent to $0.58 from $0.50 in first-quarter 2008 - Diluted EPS, excluding $0.05 in amortization of intangible assets from the 2003 spin-off, increased 14.5 percent to $0.63 from $0.55 in first-quarter 2008 - Total net...

Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share

- Launch of Generic Yasmin(R) Oral Contraceptive Contributes to Higher U.S. Generic Sales - Continued Strong European and Rest of the World Sales - Increased Proprietary Product Sales - Company Reiterates 2008 Adjusted EPS Guidance of $2.75 - $...

Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share

- Strong European and Rest of the World Sales - Proprietary Product Sales Increase, Portfolio Expanded - Company Provides Updated Adjusted Calendar 2008 EPS Guidance of $2.75 - $3.05 MONTVALE, N.J., May 8 /PRNewswire-FirstCall/ -- Barr Pharm...

Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter

MONTVALE, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) today reported net earnings of $128.4 million, or $1.18 per share, for the year ended December 31, 2007 on revenues of $2.5 billion. On a non-GAAP basis, adjusted earnings per share were $3.16 for 2007. ...

Sonic Foundry reports GAAP loss as Q2 revenues rise

Madison, Wis . - Sonic Foundry has reported a GAAP loss of $1.9 million, or five cents per share, for the second quarter of fiscal 2007, but the company's quarterly revenues continue to rise. Sonic Foundry, developer of the Mediasite communications technology, said its Q2 net loss compares to...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... recurring costs were $19.0 million. - gaap net loss and net loss per share for the quarter we...do not have any standardized meaning prescribed by gaap and therefore may not be comparable to similar mea...ave provided a reconciliation of these measures to gaap in the attached tables. Conference Call ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...opment costs. The differences between U.S. gaap and non U.S. gaap financial results are itemized in Tables 2 and 3 a...d in isolation or as a substitute for reported, or gaap net loss and diluted net loss per common share. ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... +27% Non gaap operating income $116 million -53% US gaap operating income $35 million +$102 million Non gaap diluted earnings per ADS (using actual Q2 2009...

NxStage Reports Second Quarter 2009 Financial Results

... non-GAAP financial measure to its most comparable gaap financial measure is in the exhibits to this press...s consolidated financial statements presented on a gaap basis. This non-GAAP measure is not in accordance ... supplement, and to be viewed in conjunction with, gaap financial measures. The non-GAAP financial measur...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...ached in this press release is a reconciliation of gaap to non-GAAP calculations. Selected Product...,350 Notes to reconciliation of our gaap statements of operations to our adjusted statement...,531 Notes to reconciliation of our gaap statements of operations to our adjusted statement...